Avost Plus Eye Drop

Avost Plus Eye Drop is manufactured by Ibn-Sina Pharmaceuticals Ltd. Avost Plus Eye Drop contains 0.004%+0.5% Travoprost + Timolol Maleate. It is Drugs for miotics and glaucoma class drug.

Travoprost and Timolol reduce intraocular pressure (IOP) by complementary mechanisms of action. Travoprost is a prostaglandin analogue which reduces IOP by increasing trabecular outflow & uveoscleral outflow. Timolol is a non-selective beta adrenergic receptor blocker that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anesthetic (membrane stabilizing) activity. It lowers IOP by decreasing the formation of aqueous humor in the ciliary epithelium.


This Sterile Ophthalmic Solution is used for the treatment of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension who are insufficiently responsive to single therapy with prostaglandin analogue or topical beta blocker.

Brand Name: Avost Plus
Generic: Travoprost + Timolol Maleate
Weight: 0.004%+0.5%
Type: Eye Drop
Therapeutic Class: Drugs for miotics and glaucoma
Manufacturer: Ibn-Sina Pharmaceuticals Ltd
Price: 700.00
Last Updated: November 22, 2020 at 6:15 pm


Avost Plus contains Travoprost + Timolol Maleate 0.004%+0.5%. Avost Plus Dosage:

Instill one drop in the conjunctival sac of the affected eye(s) once daily at about the same time each day, preferably in the evening.


Side Effects

No serious adverse reactions are reported. Most frequently reported side effects are ocular hyperemia.


For ophthalmic use only. Patients should remove their contact lenses prior to instilling this preparation and should not insert their lenses until 15 minutes after instillation of the preparation.

Avost Plus



Pregnancy Lactation use

Use in pregnancy: There are no adequate and well-controlled studies in pregnant women. It should not be used during pregnancy.

Use in lactation: Caution should be exercised when Avost Plus is administered to a nursing mother.


Contraindicated in patients who are hypersensitive to Travoprost, Timolol or any of the components of this preparation.

Special Warning

Use in children: Safety and effectiveness in pediatric patients have not been established.

Use in elderly patients: No overall differences in safety and effectiveness have been observed between elderly and other adult patients.

Acute Overdose


Interaction with other Medicine


Storage Condition

Store in a cool, dry place, away from heat and direct light. Keep out of the reach of children. Do not use more than 4 weeks after opening the bottle